Results 51 to 60 of about 16,099 (284)

Secondary spontaneous pneumothorax in a patient of allergic bronchopulmonary aspergillosis: an unusual presentation [PDF]

, 2021
Allergic bronchopulmonary aspergillosis (ABPA) is a complex immunologic pulmonary disorder caused by hypersensitivity to fungus, Aspergillus fumigates. It clinically manifests with non-specific respiratory and systemic symptoms. ABPA is typically seen in
Kumar, Surender, Sandal, Shivali
core   +2 more sources

Successful Treatment with Benralizumab for Allergic Bronchopulmonary Aspergillosis That Developed after Disastrous Heavy Rainfall in Western Japan

Internal medicine, 2020
We herein report a 56-year-old woman who developed allergic bronchopulmonary aspergillosis (ABPA) possibly due to fungal exposure after disastrous heavy rainfall in Western Japan in 2018.
H. Matsuura, K. Fujiwara, H. Omori, Kiriko Onishi, Tadahiro Kuribayashi, S. Mitsumune, Yukiko Takigawa, K. Kudo, D. Minami, A. Sato, Ken Sato, T. Shibayama   +11 more
semanticscholar   +1 more source

Management of allergic bronchopulmonary aspergillosis: a review and update

Therapeutic Advances in Respiratory Disease, 2012
Since the first description of allergic bronchopulmonary aspergillosis (ABPA) in the 1950s there have been numerous studies that have shed light on the characteristics and immunopathogenesis of this disease.
Mahboobeh Mahdavinia, Leslie C. Grammer
doaj   +1 more source

Molecular allergen sensitization of Aspergillus fumigatus between allergic bronchopulmonary aspergillosis and A fumigatus‐sensitized asthma in Guangzhou, Southern China

Journal of clinical laboratory analysis (Print), 2020
Few studies have assessed the sensitization of mycotic allergens and Aspergillus fumigatus molecular allergens. This study aimed to investigate the relationships of A fumigatus components and mycotic allergens in allergic bronchopulmonary aspergillosis ...
W. Luo, Haisheng Hu, Zehong Wu, N. Wei, Huimin Huang, P. Zheng, Yong Liu, Baoqing Sun   +7 more
semanticscholar   +1 more source

CT‐P39 Compared With Reference Omalizumab in Chronic Spontaneous Urticaria: Results From a Double‐Blind, Randomized, Active‐Controlled, Phase 3 Study

Allergy, EarlyView.
This study investigated the therapeutic equivalence of CT‐P39 (an omalizumab biosimilar) and EU‐approved reference omalizumab (ref‐OMA) in patients with chronic spontaneous urticaria. Therapeutic equivalence between CT‐P39 and ref‑OMA (300 mg) was demonstrated by the primary endpoint – confidence intervals of the treatment difference in mean change ...
Sarbjit S. Saini, Marcus Maurer, Yevgeniya Dytyatkovska, Ewa Springer, Maria Ratkova, Borislava Krusheva, Chun Wook Park, Grazyna Pulka, Marta Chełmińska, Adam Reich, Sunghyun Kim, Keumyoung Ahn, Suyoung Kim, Sewon Lee, Jieun Ka, Jongho Kim, Clive Grattan   +16 more
wiley   +1 more source

Immune responses to airborne fungi and non-invasive airway diseases. [PDF]

, 2014
Inhalation of fungal particles is a ubiquitous way of exposure to microorganisms during human life; however, this exposure may promote or exacerbate respiratory diseases only in particular exposure conditions and human genetic background.
Niculita-Hirzel, Hélène, Roger, Thierry, Vacher, Gaëlle   +2 more
core   +1 more source

Allergic bronchopulmonary aspergillosis with coexistant aspergilloma: a case report

Journal of Medical Case Reports, 2010
Introduction The coexistence of allergic bronchopulmonary aspergillosis and aspergilloma is rare. Case presentation We present the case of a 56-year-old Caucasian man who worked as a farmer, with infiltrates in the right lower and middle lung lobes ...
Kern Izidor, Lopert Anton
doaj   +1 more source

Mepolizumab use in cystic fibrosis‐associated allergic bronchopulmonary aspergillosis

Respirology Case Reports, 2020
Allergic bronchopulmonary aspergillosis (ABPA) is common in cystic fibrosis (CF). Treatment is challenging and the relapse rate is high. Standard therapy is oral steroids and antifungals.
M. Boyle, S. Mulrennan, S. Morey, S. Vekaria, N. Popowicz, A. Tai   +5 more
semanticscholar   +1 more source

Clinical Characteristics of Difficult‐To‐Treat Allergic Bronchopulmonary Aspergillosis and Its Prediction Score

Allergy, EarlyView.
A retrospective cohort of newly diagnosed treatment‐naive patients with ABPA in Japan who were followed up for up to 3 years after the primary diagnosis was analyzed to explore the clinical remission rate and clinical characteristics of ABPA resistant to standard treatment or prone to exacerbation during/after treatment.
Jun Tanaka, Tsuyoshi Oguma, Takashi Ishiguro, Hirokazu Taniguchi, Teruaki Nishiuma, Hiroki Tateno, Hisako Matsumoto, Naoki Koshimizu, Yutaka Ito, Kazuto Matsunaga, Hidekazu Matsushima, Yoshitaka Uchida, Koshi Yokomura, Hirotaka Yasuba, Junko Suzuki, Shigeaki Hattori, Naoki Okada, Katsuyoshi Tomomatsu, Koichiro Asano, on behalf of ABPM Research Program   +19 more
wiley   +1 more source

Specific Antibodies to Recombinant Allergens of \u3cem\u3eAspergillus fumigatus\u3c/em\u3e in Cystic Fibrosis Patients with ABPA [PDF]

, 2006
Background Aspergillus fumigatus, a widely distributed fungus, has been implicated in causing life threatening infections as well as severe asthma and allergic diseases in man.
Bansal, Naveen K., Knutsen, Alan P., Kurup, Viswanath P., Moss, Richard B.   +3 more
core   +1 more source